MedPath

The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot

Not Applicable
Completed
Conditions
Impairment of Oral Perception
Interventions
Dietary Supplement: Sucrose
Dietary Supplement: Sucralose
Registration Number
NCT02335008
Lead Sponsor
Yale University
Brief Summary

The goal of this study is to test the hypothesis that repeated consumption of artificial sweetener reduces sweet taste intensity.

Detailed Description

Significant controversy surrounds the possibility that consumption of artificial sweeteners (AFS) leads to weight gain. Some studies have found correlations between AFS use and weight gain and/or diabetes \[1-4\] while others have indicated that AFSs may aid in weight loss \[5\] or have no effects on body mass index (BMI) \[6\]. In rats, exposure to AFS leads to reduced chow intake following a sweet preload \[7, 8\], higher body weight \[9, 10\] and increased glucose responses and decreased GLP1 release following an oral glucose tolerance test \[11\] compared to exposure to caloric sweeteners. Given that the five FDA approved AFSs are found in thousands of foods \[12\] this marks a clear and significant gap in knowledge. Our preliminary data demonstrate a 3-fold decrease in sweet taste sensitivity following consumption of a beverage sweetened with two packets of Splenda for just 10 days. These data provide strong evidence that repeated exposure to sucralose reduces perception of sweet taste intensity, most likely by down-regulation of the sweet taste receptor. Therefore, it is imperative that we gain a greater understanding of the consequences of AFS use, since alterations in sweet taste perception that occur in response to AFS exposure may promote weight gain.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Healthy
  • Fluent in English
Read More
Exclusion Criteria
  • History of oral nerve damage,
  • presence of known taste or smell disorder,
  • food allergies or sensitivities (for example nuts, lactose, artificial sweeteners),
  • history of CNS disease,
  • diabetes,
  • history of DSM-IV major psychiatric disorder, including alcohol and substance abuse, chronic use of medication that may affect taste,
  • conditions that may interfere with gustatory or olfactory perception (colds, seasonal allergies, recent smoking history),
  • aberrant stimulus ratings,
  • contra-indication for fMRI,
  • uncomfortable swallowing in supine position.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SucroseSucroseParticipants will rate sweetness, sourness, saltiness, bitterness and umami intensity of various taste stimuli. Next they will consume a flavored beverage with sucrose.
SucraloseSucraloseParticipants will rate sweetness, sourness, saltiness, bitterness and umami intensity of various taste stimuli. Next they will consume a flavored beverage with sucralose.
Primary Outcome Measures
NameTimeMethod
Ratings of taste sensitivityup to one week after intervention

general labeled magnitude scale ratings of taste intensity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The John B Pierce Laboratory

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath